

McqMate
Q. |
Which of the following treatment outcomes is associated with patients who have DCIS, according to prospective randomized trials? |
A. | In NSABP B-17, the actuarial rate of breast cancer recurrence after 12 years in patients who received surgery only was 24%. |
B. | In NSABP B-17, the actuarial rate of breast cancer recurrence after 12 years in patients who received surgery plus breast irradiation was 16%. |
C. | In NSABP B-24, breast irradiation reduced the risk of breast cancer recurrence in all subgroups except for the patients with positive surgical margins. |
D. | In EORTC 10853, the subtype of DCIS histology had no effect on patients' risk for breast cancer recurrence. |
Answer» B. In NSABP B-17, the actuarial rate of breast cancer recurrence after 12 years in patients who received surgery plus breast irradiation was 16%. |
View all MCQs in
Important Questions Repeated in MD ExamsNo comments yet